BIOMAT Database Logo BIOMAT Database Logo

Ochrobactrum anthropi bacteremia in pediatric oncology patients. 2002

Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
Department of Pediatric Hematology-Oncology, University of Crete, Heraklion, Greece.

Ochrobactrum anthropi is an emerging pathogen in immunocompromised hosts, particularly in patients with indwelling catheters. We report the characteristics of 14 O. anthropi bacteremic episodes in 11 children with Hickman-type central catheters. Children presented with fever and nonspecific clinical manifestations. Bacteremia was successfully treated with antibiotics, but catheter removal was necessary to achieve cure in four cases.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias

Related Publications

Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
Ochrobactrum anthropi bacteremia.
January 1999, Heart & lung : the journal of critical care,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
Ochrobactrum anthropi bacteremia in a child.
August 1993, Delaware medical journal,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
[Ochrobactrum anthropi bacteremia developed after cholangiopancreatography].
July 2007, Mikrobiyoloji bulteni,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
Clinical characteristics of Ochrobactrum anthropi bacteremia.
April 2013, Journal of clinical microbiology,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
[Catheter- associated bacteremia caused by Ochrobactrum anthropi].
January 2009, Medicina,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
[Ochrobactrum anthropi bacteremia in a patient with AIDS].
September 1998, Medicina clinica,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
Ochrobactrum anthropi bacteremia in a patient on hemodialysis.
June 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
Clinical and microbiologic characteristics of Ochrobactrum anthropi bacteremia.
February 1998, Journal of the Formosan Medical Association = Taiwan yi zhi,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
Seven cases of bacteremia due to Ochrobactrum anthropi.
December 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Eftichia Stiakaki, and Emmanouil Galanakis, and George Samonis, and Athanasia Christidou, and Sofia Maraka, and Yiannis Tselentis, and Maria Kalmanti
Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child.
January 1994, Infection,
Copied contents to your clipboard!